CLColgate-Palmolive

$92.06
Colgate-Palmolive logo

Price

$92.06+11%1Y
1M+2.2%1Y+11%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Above average
7/10
Value23
Quality97
Momentum63
Growth66
Strongest Quality, weakest Value · ranked vs Consumer Defensive peers. The five questions below judge the company on its own terms.
What they do

Colgate-Palmolive Company (together with its subsidiaries, “we,” “us,” “our,” the “Company” or “Colgate-Palmolive”) is a caring, innovative growth company united behind our purpose to reimagine a healthier future for all people, their pets and our planet. To achieve our business and financial objectives and deliver peer-leading performance and total shareholder return, we are focused on driving organic sales growth; delivering consistent, compounded earnings per share growth; achieving operational efficiencies; and driving growth in free cash flow along with the efficient use of our balance sheet.

In the company’s own words · 10-K filed Feb 23, 2026 · SEC EDGAR

P/E (TTM)36.4
Market Cap$71.60B
1Y Return+11%
5Y Return+30%

Business segments

Q2 2026 · $4.17B

The company’s own SEC segment disclosure.

  • Latin America$1.37B33%
  • EMEA$1.12B27%
  • North America$891.0M21%
  • Asia Pacific$782.0M19%

Colgate-Palmolive (CL) reported revenue of $5.36B in Q2 2026 (quarter ended June 30, 2026), up 4.9% from the same quarter a year earlier. That came with a gross margin of 61% and net income of $693M (13% of revenue). For the full year FY2025, revenue was $20.4B (+1.4% year on year) and net income $2.13B. Its largest region in 2026-Q2 was Latin America at $1.37B, 33% of the disclosed total, just ahead of EMEA at 27%.

Raw charts

11 series · TTM

As reported to the SEC, without any scoring.